Brief: Parnell Pharmaceuticals says expects to continue to receive patent grants relating to Zydax in 2016
24/02/2016 12:02
Feb 24 (Reuters) - Parnell Pharmaceuticals Holdings Ltd PARN.O : * Says expect to continue to receive patent grants relating to Zydax in 2016 * Says 2016 total group revenue expected to be US$14 to US$16 million * Source text for Eikon ID:nGNXMNPBGa * Further company coverage PARN.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln